These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 33777925)

  • 1. OPCML Methylation and the Risk of Ovarian Cancer: A Meta and Bioinformatics Analysis.
    Shao Y; Kong J; Xu H; Wu X; Cao Y; Li W; Han J; Li D; Xie K; Wu J
    Front Cell Dev Biol; 2021; 9():570898. PubMed ID: 33777925
    [No Abstract]   [Full Text] [Related]  

  • 2. Opioid-binding protein/cell adhesion molecule-like (OPCML) gene and promoter methylation status in women with ovarian cancer.
    Czekierdowski A; Czekierdowska S; Szymanski M; Wielgos M; Kaminski P; Kotarski J
    Neuro Endocrinol Lett; 2006 Oct; 27(5):609-13. PubMed ID: 17159813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylation of OPCML promoter in ovarian cancer tissues predicts poor patient survival.
    Zhou F; Tao G; Chen X; Xie W; Liu M; Cao X
    Clin Chem Lab Med; 2014 May; 52(5):735-42. PubMed ID: 24327526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between RASSF1A gene promoter methylation and the susceptibility and prognosis of melanoma: A meta-analysis and bioinformatics.
    Shao C; Dai W; Li H; Tang W; Jia S; Wu X; Luo Y
    PLoS One; 2017; 12(2):e0171676. PubMed ID: 28207831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Deletion of OPCML gene and promoter methylation in ovarian epithelial carcinoma].
    Zhang J; Ye F; Chen HZ; Ye DF; Lu WG; Xie X
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Apr; 28(2):173-7. PubMed ID: 16733898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of circulating methylated opioid binding protein/cell adhesion molecule-like gene as a biomarker for ovarian carcinoma.
    Zhou F; Ma M; Tao G; Chen X; Xie W; Wang Y; Cao X
    Clin Lab; 2014; 60(5):759-65. PubMed ID: 24839818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of OPCML expression and the correlation with CpG island methylation and LOH in ovarian serous carcinoma.
    Chen H; Ye F; Zhang J; Lu W; Cheng Q; Xie X
    Eur J Gynaecol Oncol; 2007; 28(6):464-7. PubMed ID: 18179137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of opioid binding protein/cell adhesion molecule-like gene expression in gastric cancer.
    Zhang N; Xu J; Wang Y; Heng X; Yang L; Xing X
    Oncol Lett; 2018 Jun; 15(6):9973-9977. PubMed ID: 29805691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of opioid binding protein/cell adhesion molecule-like promoter methylation in bladder carcinoma.
    Duarte-Pereira S; Paiva F; Costa VL; Ramalho-Carvalho J; Savva-Bordalo J; Rodrigues A; Ribeiro FR; Silva VM; Oliveira J; Henrique R; Jerónimo C
    Eur J Cancer; 2011 May; 47(7):1106-14. PubMed ID: 21273058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Correlations of CpG island methylator phenotype and OPCML gene methylation to carcinogenesis of hepatocellular carcinoma].
    Liu WJ; Wang L; Wang JP; Li JQ; Zhang CQ; Zheng L; Yuan YF
    Ai Zheng; 2006 Jun; 25(6):696-700. PubMed ID: 16764763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RASSF1A promoter methylation is associated with increased risk of thyroid cancer: a meta-analysis.
    Shou F; Xu F; Li G; Zhao Z; Mao Y; Yang F; Wang H; Guo H
    Onco Targets Ther; 2017; 10():247-257. PubMed ID: 28123306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RAS-mediated epigenetic inactivation of OPCML in oncogenic transformation of human ovarian surface epithelial cells.
    Mei FC; Young TW; Liu J; Cheng X
    FASEB J; 2006 Mar; 20(3):497-9. PubMed ID: 16384911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association between CDH1 promoter methylation and patients with ovarian cancer: a systematic meta-analysis.
    Wang Q; Wang B; Zhang YM; Wang W
    J Ovarian Res; 2016 Apr; 9():23. PubMed ID: 27067410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations of MGMT promoter hypermethylation with squamous intraepithelial lesion and cervical carcinoma: A meta-analysis.
    Huang J; Luo JY; Tan HZ
    PLoS One; 2019; 14(10):e0222772. PubMed ID: 31574102
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Shen S; Chen X; Li H; Sun L; Yuan Y
    J Cancer; 2018; 9(11):1932-1942. PubMed ID: 29896277
    [No Abstract]   [Full Text] [Related]  

  • 16. Quantitative assessment of aberrant
    Ruan J; Xu P; Fan W; Deng Q; Yu M
    Cancer Manag Res; 2018; 10():3033-3046. PubMed ID: 30214298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of
    Wang XB; Cui NH; Liu XN; Ma JF; Zhu QH; Guo SR; Zhao JW; Ming L
    Front Genet; 2018; 9():258. PubMed ID: 30065752
    [No Abstract]   [Full Text] [Related]  

  • 18. Meta-analysis demonstrates no association between p16
    Jiang Y; Yan F; Liang L; Wan Y; Liu J; Cheng W
    Arch Gynecol Obstet; 2017 Mar; 295(3):697-704. PubMed ID: 28000027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of luteolin on the methylation status of the OPCML gene and cell growth in breast cancer cells.
    Dong X; Zhang J; Yang F; Wu J; Cai R; Wang T; Zhang J
    Exp Ther Med; 2018 Oct; 16(4):3186-3194. PubMed ID: 30214542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association Between Tissue Inhibitor of Metalloproteinase-3 Gene Methylation and Gastric Cancer Risk: A Meta-Analysis.
    Cao J; Li Z; Yang L; Liu C; Luan X
    Genet Test Mol Biomarkers; 2016 Aug; 20(8):427-31. PubMed ID: 27314831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.